CMS sheds light on the future of medical schemes and NHI in South Africa
A recent interview with Dr Sipho Kabane, the Registrar and Chief Executive at the Council for Medical Schemes is now available. They discuss various issues including the role of the CMS and its function to assure affordable medical schemes, the delay in more affordable cover in low-income families as well as the role of medical schemes once NHI is implemented in South Africa.
Follow the below link for the recorded interview.
Recent Posts
Joint Scientific Consultation EU Strategies for Medical Device Companies
The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...
Insights on EU Joint Clinical Assessment for High-Risk Medical Devices
EU Joint Clinical Assessment is a distinct, harmonised process that operates separately from CE marking. It produces comparative clinical evidence on selected high-risk devices to support more consistent national reimbursement decisions across EU member states. Insights from the
USTR Germany Pharma Investigation and its Impact on Global Drug Pricing
The USTR Germany Pharma Investigation has exposed how Germany’s pharmaceutical reimbursement policies force American patients to finance a disproportionately large share of worldwide drug research and development. By systematically suppressing prices below sustainable levels, these practices erod...